The global single-use bioprocessing market is undergoing rapid transformation as biopharmaceutical manufacturers increasingly adopt flexible, scalable, and cost-efficient manufacturing technologies. Single-use systems are gaining traction across biologics, vaccines, monoclonal antibodies, recombinant proteins, and advanced therapies because they can reduce cleaning requirements, shorten...